BRAIN Biotech AG ("BRAIN") is a pioneer of industrial biotechnology. We create innovative bio-based solutions applying a world class biotechnology portfolio to the BRAIN BioArchive. We deliver value from concept to commercialization and beyond.
Want to stay up to date on all the activities at BRAIN Biotech? Receive our newsletter regularly.
Interested in getting to know more about what drives the company and its people to find biotechnological answers to the questions of today’s industries? Check out our stories here:
Based on unique cell-based assay systems, within its SALT programs BRAIN focusses on the reduction of salt in foods.
Edible plants provide bioactive compounds that combat harmful organisms. BRAIN’s FRESCO program identifies the best anti-microbial candidates.
Our DOLCE R&D program was completed at the end of 2020, and gave rise to two approaches for BRAIN and the food industry.
Aurase® is an enzymatic active ingredient developed by BRAIN for the treatment of open wounds. The active mechanism was inspired by the common green bottle fly.
Microorganisms from the BRAIN bioarchive extract precious metals from e-waste, ashes, slags and other waste streams in an environmentally friendly way.
In the TRiP2Application programs, BRAIN offers unique cell-based assay systems for the identification of novel ingredients for food & cosmetics. In addition, cell models developed by BRAIN enable the development of biological deodorants and aluminum-free antiperspirants.
Dear Customers, dear Ladies and Gentlemen, we want to update you on how BRAIN Biotech is dealing with the situation imposed on public life in Germany during the Corona pandemic.
